{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:17:06Z","timestamp":1784125026412,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00066-021-01758-5","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T10:03:06Z","timestamp":1615888986000},"page":"416-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Interstitial single fraction brachytherapy for malignant pulmonary tumours"],"prefix":"10.1007","volume":"197","author":[{"given":"Ali","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6450-297X","authenticated-orcid":false,"given":"Michael","family":"Pinkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hathal","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Hermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Temming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bischoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"1758_CR1","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez\u00a0DR, Tang\u00a0C, Zhang\u00a0J et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a\u00a0multi-institutional, phase II, randomized study. J\u00a0Clin Oncol 37:1558\u20131565","journal-title":"J Clin Oncol"},{"key":"1758_CR2","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar\u00a0P, Wardak\u00a0Z, Gerber\u00a0DE et al (2018) Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 4:e173501","journal-title":"JAMA Oncol"},{"key":"1758_CR3","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma\u00a0DA, Olson\u00a0R, Harrow\u00a0S et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a\u00a0randomised, phase 2, open-label trial. Lancet 393:2051\u20132058","journal-title":"Lancet"},{"issue":"25","key":"1758_CR4","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma\u00a0DA, Olson\u00a0R, Harrow\u00a0S et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J\u00a0Clin Oncol 38(25):2830\u20132838. https:\/\/doi.org\/10.1200\/JCO.20.00818","journal-title":"J Clin Oncol"},{"key":"1758_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang\u00a0JY, Senan\u00a0S, Paul\u00a0MA et al (2015) Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a\u00a0pooled analysis of two randomised trials. Lancet Oncol 16:630\u2013637","journal-title":"Lancet Oncol"},{"key":"1758_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01687-9","author":"M Loi","year":"2020","unstructured":"Loi\u00a0M, Franceschini\u00a0D, Dominici\u00a0L et al (2020) Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy. Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-020-01687-9","journal-title":"Strahlenther Onkol"},{"key":"1758_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00066-020-01627-7","volume":"196","author":"L Nicosia","year":"2020","unstructured":"Nicosia\u00a0L, Cuccia\u00a0F, Mazzola\u00a0R et\u00a0al (2020) Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Strahlenther Onkol 196:813\u2013820","journal-title":"Strahlenther Onkol"},{"key":"1758_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman\u00a0S, Weichselbaum\u00a0RR (1995) Oligometastases. J\u00a0Clin Oncol 13:8\u201310","journal-title":"J Clin Oncol"},{"key":"1758_CR9","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1097\/JTO.0b013e318208c7a3","volume":"6","author":"N Tselis","year":"2011","unstructured":"Tselis\u00a0N, Ferentinos\u00a0K, Kolotas\u00a0C et al (2011) Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J\u00a0Thorac Oncol 6:545\u2013552","journal-title":"J Thorac Oncol"},{"key":"1758_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","volume":"196","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger\u00a0M, Baus\u00a0WW, Blanck\u00a0O et\u00a0al (2020) Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 196:417\u2013420","journal-title":"Strahlenther Onkol"},{"key":"1758_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12094-017-1635-0","volume":"19","author":"A Youroukou","year":"2017","unstructured":"Youroukou\u00a0A, Gkiozos\u00a0I, Kalaitzi\u00a0Z et\u00a0al (2017) The potential role of brachytherapy in the irradiation of patients with lung cancer: a\u00a0systematic review. Clin Transl Oncol 19:945\u2013950","journal-title":"Clin Transl Oncol"},{"key":"1758_CR12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00066-018-1358-3","volume":"194","author":"G Chatzikonstantinou","year":"2018","unstructured":"Chatzikonstantinou\u00a0G, Zamboglou\u00a0N, Archavlis\u00a0E et al (2018) CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a\u00a020-year single-institute experience. Strahlenther Onkol 194:1171\u20131179","journal-title":"Strahlenther Onkol"},{"key":"1758_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.brachy.2019.08.001","volume":"18","author":"G Chatzikonstantinou","year":"2019","unstructured":"Chatzikonstantinou\u00a0G, Zamboglou\u00a0N, Baltas\u00a0D, Ferentinos\u00a0K, Bon\u00a0D, Tselis\u00a0N (2019) Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: a single-institute experience. Brachytherapy 18:829\u2013834","journal-title":"Brachytherapy"},{"key":"1758_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s00066-017-1120-2","volume":"193","author":"K Mohnike","year":"2017","unstructured":"Mohnike\u00a0K, Neumann\u00a0K, Hass\u00a0P et al (2017) Radioablation of adrenal gland malignomas with interstitial high-dose-rate brachytherapy: efficacy and outcome. Strahlenther Onkol 193:612\u2013619","journal-title":"Strahlenther Onkol"},{"key":"1758_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00066-008-1815-5","volume":"184","author":"M Pech","year":"2008","unstructured":"Pech\u00a0M, Wieners\u00a0G, Kryza\u00a0R et al (2008) CT-guided brachytherapy (CTGB) versus interstitial laser ablation (ILT) of colorectal liver metastases: an intraindividual matched-pair analysis. Strahlenther Onkol 184:302\u2013306","journal-title":"Strahlenther Onkol"},{"key":"1758_CR16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00066-008-1718-5","volume":"184","author":"N Peters","year":"2008","unstructured":"Peters\u00a0N, Wieners\u00a0G, Pech\u00a0M et al (2008) CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a\u00a0prospective phase II trial. Strahlenther Onkol 184:296\u2013301","journal-title":"Strahlenther Onkol"},{"key":"1758_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.brachy.2019.08.003","volume":"18","author":"P Hass","year":"2019","unstructured":"Hass\u00a0P, Mohnike\u00a0K, Kropf\u00a0S et\u00a0al (2019) Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies. Brachytherapy 18:823\u2013828","journal-title":"Brachytherapy"},{"key":"1758_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.5114\/jcb.2018.79335","volume":"10","author":"MK Chan","year":"2018","unstructured":"Chan\u00a0MK, Lee\u00a0VW, Kadoya\u00a0N et al (2018) Single fraction computed tomography-guided high-dose-rate brachytherapy or stereotactic body radiotherapy for primary and metastatic lung tumors? J\u00a0Contemp Brachytherapy 10:446\u2013453","journal-title":"J Contemp Brachytherapy"},{"key":"1758_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01243894-200610000-00008","volume":"1","author":"QT Le","year":"2006","unstructured":"Le\u00a0QT, Loo\u00a0BW, Ho\u00a0A et al (2006) Results of a\u00a0phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J\u00a0Thorac Oncol 1:802\u2013809","journal-title":"J Thorac Oncol"},{"key":"1758_CR20","doi-asserted-by":"publisher","first-page":"6483626","DOI":"10.1155\/2018\/6483626","volume":"2018","author":"S Morias","year":"2018","unstructured":"Morias\u00a0S, Marcu\u00a0LG, Short\u00a0M et al (2018) Treatment-related adverse effects in lung cancer patients after stereotactic ablative radiation therapy. J\u00a0Oncol 2018:6483626","journal-title":"J Oncol"},{"key":"1758_CR21","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1378\/chest.127.6.2237","volume":"127","author":"J Ricke","year":"2005","unstructured":"Ricke\u00a0J, Wust\u00a0P, Wieners\u00a0G et al (2005) CT-guided interstitial single-fraction brachytherapy of lung tumors: phase I results of a\u00a0novel technique. Chest 127:2237\u20132242","journal-title":"Chest"},{"key":"1758_CR22","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1055\/s-2003-37830","volume":"175","author":"N Hosten","year":"2003","unstructured":"Hosten\u00a0N, Stier\u00a0A, Weigel\u00a0C et al (2003) Laser-induced thermotherapy (LITT) of lung metastases: description of a\u00a0miniaturized applicator, optimization, and initial treatment of patients. Rofo 175:393\u2013400","journal-title":"Rofo"},{"key":"1758_CR23","first-page":"339","volume":"24","author":"K Steinke","year":"2004","unstructured":"Steinke\u00a0K, Sewell\u00a0PE, Dupuy\u00a0D et\u00a0al (2004) Pulmonary radiofrequency ablation\u2014an international study survey. Anticancer Res 24:339\u2013343","journal-title":"Anticancer Res"},{"key":"1758_CR24","doi-asserted-by":"publisher","first-page":"FSO471","DOI":"10.2144\/fsoa-2019-0120","volume":"6","author":"F Londero","year":"2020","unstructured":"Londero\u00a0F, Grossi\u00a0W, Morelli\u00a0A et\u00a0al (2020) Surgery versus stereotactic radiotherapy for treatment of pulmonary metastases. A systematic review of literature. Future Sci OA 6:FSO471","journal-title":"Future Sci OA"},{"key":"1758_CR25","first-page":"e7305","volume":"12","author":"JC Von Einem","year":"2020","unstructured":"Von Einem\u00a0JC, Stintzing\u00a0S, Modest\u00a0DP, Wiedemann\u00a0M, Furweger\u00a0C, Muacevic\u00a0A (2020) Frameless single robotic radiosurgery for pulmonary metastases in colorectal cancer patients. Cureus 12:e7305","journal-title":"Cureus"},{"key":"1758_CR26","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.21037\/jtd.2018.07.26","volume":"10","author":"M Khadige","year":"2018","unstructured":"Khadige\u00a0M, Salleron\u00a0J, Marchesi\u00a0V, Oldrini\u00a0G, Peiffert\u00a0D, Beckendorf\u00a0V (2018) Cyberknife\u00ae stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24\u00a0months. J\u00a0Thorac Dis 10:4976\u20134984","journal-title":"J Thorac Dis"},{"key":"1758_CR27","first-page":"43","volume":"5","author":"A Mihai","year":"2017","unstructured":"Mihai\u00a0A, Mu\u00a0Y, Armstrong\u00a0J et al (2017) Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease. J\u00a0Radiosurg SBRT 5:43\u201353","journal-title":"J Radiosurg SBRT"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01758-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-021-01758-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01758-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T15:09:18Z","timestamp":1622646558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-021-01758-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1007\/s00066-021-01758-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Rashid, M.\u00a0Pinkawa, H.\u00a0Haddad, H.\u00a0Hermani, S.\u00a0Temming, A.\u00a0Sch\u00e4fer, P.\u00a0Bischoff and A.\u00a0Kov\u00e1cs declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}